Security key
00972D105
Akebia Therapeutics, Inc. - COMMON STOCK (AKBA)
CUSIP: 00972D105
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 56,991,509
- Total 13F value
- $104,293,412
- Share change
- +914,077
- Put/Call ratio
- 80%
- SEC-reported price per share
- $1.83
- Number of holders
- 108
- Value change
- +$2,027,480
- Number of buys
- 61
- Number of sells
- 36
- Shares outstanding
- 270,093,163
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
108
Top holders
10
AKBA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Akebia Therapeutics, Inc. SEC filings
Akebia Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00972D105
Recent filing periods:
Ownership snapshot
Top reported holders of AKBA - Akebia Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Alerce Investment Managem...
Disclosed value leader
Alerce Investment Managem...
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 6%
Showing 1-6 of 15 holder rows.
Quick read
Alerce Investment Management, L.P. leads the comparable SEC ownership view at 6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Alerce Investment Management, L.P.'s linked filing trail.
Comparable ownership
Top 5
Alerce Investment Management, L.P.
6%
VANGUARD GROUP INC
2.8%
ACADIAN ASSET MANAGEMENT LLC
2.6%
RENAISSANCE TECHNOLOGIES LLC
1.8%
BlackRock Finance, Inc.
1.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Alerce Investment Management, L.P. |
13F
Company
|
6%
|
$20,094,348
16,205,119 shares
|
— | 31 Dec 2023 |
| VANGUARD GROUP INC |
13F
Company
|
2.8%
|
$9,433,265
7,607,472 shares
|
— | 31 Dec 2023 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
2.6%
|
$8,574,000
6,915,503 shares
|
— | 31 Dec 2023 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
1.8%
|
$5,926,000
4,779,383 shares
|
— | 31 Dec 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
1.2%
|
$3,872,301
3,122,824 shares
|
— | 31 Dec 2023 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
0.96%
|
$3,223,984
2,599,987 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
108
Shares
56,991,509
Rows available
108
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
108
Q1 2024 holders
108
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend